SAN DIEGO, May 30, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading enterprise R&D software and services company, today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.
Offered through the Accelrys Academic Program, the licensed software includes the scientifically enabled, enterprise-scalable Accelrys Enterprise Platform supporting multi-center, collaborative information sharing and scientific innovation across partnering research organizations. The system also includes Accelrys Pipeline Pilot™ (the platform's scientific authoring solution), the Cloud-based Accelrys HEOS® drug discovery information management workspace, the Accelrys Discovery Studio® modeling and simulation application and Accelrys Biological Registration software.
"Plug-and-play deployment and ease of use in a seamless integrated network requiring minimal support by internal resources were the driving factors that led our group to adopt Accelrys technology," said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M Health Center. "With upwards of thirty projects a year, we need to work together efficiently and generate results quickly with minimal time and resources spent on internal software development. The ability to create Pipeline Pilot Web applications that can be freely shared with other academic researchers inside or outside the Consortia provides a significant collaboration and innovation benefit."
Dr. Michael Mancini, associate professor in the department of Molecular and Cellular Biology at Baylor College of Medicine, and co-founder/co-director of the GCC-CG added "For several years, our assay development efforts and screening program have always had a sizable high throughput microscopy-based emphasis using Pipeline Pilot-based imaging tools. We are extremely pleased to now be able to integrate high content analysis/screening data and reporting across the entire program using HEOS."
The mission of the GCC is to build and support interdisciplinary collaborative research teams and training programs in the biological sciences and apply the resulting expertise and knowledge to the treatment and prevention of diseases. The GCC brings together preeminent principal investigators from several world-renowned research institutions including the founding members:
- Baylor College of Medicine
- Rice University
- University of Houston
- University of Texas Health Science Center at Houston (UTHealth)
- University of Texas MD Anderson Cancer Center
- University of Texas Medical Branch at Galveston
In addition to the GCC founding institutions, the GCC-CG includes The Methodist Hospital Research Institute, The University of Texas at Austin - Texas Institute for Drug and Diagnostic Development, Texas A&M Health Science Center – Institute for Biosciences and Technology, Texas Southern University and The University of Texas-El Paso.
"Large inter-institutional cooperatives focused on collaborative research and interdisciplinary training represent a new operating paradigm in academia today," said Accelrys Senior Vice President and Chief Technology Officer, Dr. Matt Hahn. "Accelrys' unifying Enterprise Platform defines a new standard in integrated research informatics for multi-center collaborations. The software package tailored for GCC and delivered through Accelrys' Academic Program provides immediate access to shared state-of-the-art solutions, enabling university partners to hit the ground running with project delivery."
Visit the Accelrys Academic microsite to learn more about how the Accelrys Academic Program is advancing academic research.
About Accelrys, Inc.
Accelrys (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Accelrys solutions are used by more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.
Press Inquiries Racepoint Group For Accelrys Marla Kertzman, 415-694-6701 firstname.lastname@example.org
SOURCE Accelrys, Inc.